JP2013544842A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544842A5
JP2013544842A5 JP2013542143A JP2013542143A JP2013544842A5 JP 2013544842 A5 JP2013544842 A5 JP 2013544842A5 JP 2013542143 A JP2013542143 A JP 2013542143A JP 2013542143 A JP2013542143 A JP 2013542143A JP 2013544842 A5 JP2013544842 A5 JP 2013544842A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
alkyl
alkenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013542143A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013544842A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/062691 external-priority patent/WO2012075174A2/en
Publication of JP2013544842A publication Critical patent/JP2013544842A/ja
Publication of JP2013544842A5 publication Critical patent/JP2013544842A5/ja
Pending legal-status Critical Current

Links

JP2013542143A 2010-12-02 2011-11-30 皮膚修復のための化合物および方法 Pending JP2013544842A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41911510P 2010-12-02 2010-12-02
US61/419,115 2010-12-02
PCT/US2011/062691 WO2012075174A2 (en) 2010-12-02 2011-11-30 Compounds and methods for skin repair

Publications (2)

Publication Number Publication Date
JP2013544842A JP2013544842A (ja) 2013-12-19
JP2013544842A5 true JP2013544842A5 (https=) 2015-01-29

Family

ID=45316123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013542143A Pending JP2013544842A (ja) 2010-12-02 2011-11-30 皮膚修復のための化合物および方法

Country Status (16)

Country Link
US (1) US20120142684A1 (https=)
EP (2) EP3195863A1 (https=)
JP (1) JP2013544842A (https=)
KR (1) KR20130119958A (https=)
CN (1) CN103282033A (https=)
AR (1) AR084144A1 (https=)
AU (1) AU2011336582A1 (https=)
BR (1) BR112013015781A2 (https=)
CA (1) CA2819471A1 (https=)
CL (1) CL2013001579A1 (https=)
MX (1) MX2013006163A (https=)
RU (1) RU2013129262A (https=)
SG (1) SG190947A1 (https=)
TW (1) TW201307313A (https=)
WO (1) WO2012075174A2 (https=)
ZA (1) ZA201303949B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103167875A (zh) * 2010-08-17 2013-06-19 阿勒根公司 用于治疗角膜浑浊的ep2或ep4激动剂
US8883139B2 (en) * 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) * 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8926963B2 (en) * 2010-08-19 2015-01-06 Allergan, Inc. Compositions and soft tissue replacement methods
US8900571B2 (en) * 2010-08-19 2014-12-02 Allergan, Inc. Compositions and soft tissue replacement methods
US8894992B2 (en) * 2010-08-19 2014-11-25 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) * 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US20140142092A1 (en) * 2012-11-16 2014-05-22 Allergan, Inc. Compounds and methods for skin repair
CA2890034A1 (en) * 2012-11-16 2014-05-22 Allergan, Inc. Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations
US9546162B2 (en) * 2013-09-27 2017-01-17 Allergan, Inc. Compounds and methods for skin repair

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
TWI249520B (en) * 1998-07-15 2006-02-21 Ono Pharmaceutical Co 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
KR20010074981A (ko) * 1998-09-14 2001-08-09 우에노 도시오 ω치환된 페닐프로스타그란딘 E 유도체 및 그 유도체를유효 성분으로 하는 약제
CN100371322C (zh) * 2001-07-16 2008-02-27 霍夫曼-拉罗奇有限公司 作为前列腺素类化合物激动剂的2-吡咯烷酮衍生物
EP2255829A3 (en) * 2001-07-23 2012-03-28 Ono Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
US20040058313A1 (en) * 2002-04-24 2004-03-25 Abreu Marcio Marc Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
ES2584606T3 (es) * 2002-10-10 2016-09-28 Ono Pharmaceutical Co., Ltd. Microesferas que comprenden ONO-1301
CA2511255C (en) * 2003-01-10 2009-04-07 F. Hoffmann-La Roche Ag 2-piperidone derivatives as prostaglandin agonists
US7855226B2 (en) 2003-02-11 2010-12-21 Allergan, Inc. Treatment of inflammatory bowel disease
US6875787B2 (en) 2003-02-11 2005-04-05 Allergan, Inc. 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
WO2005027931A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist
WO2006137472A1 (ja) * 2005-06-24 2006-12-28 Taisho Pharmaceutical Co., Ltd. プロスタグランジン誘導体
US20070232660A1 (en) * 2006-04-04 2007-10-04 Allergan, Inc. Therapeutic and delivery methods of prostaglandin ep4 agonists
US7439372B2 (en) * 2006-05-03 2008-10-21 Allergan, Inc. Therapeutic compounds
US20080167377A1 (en) * 2006-12-15 2008-07-10 Alessandra Gaiba Novel compounds
EP2120962A1 (en) * 2006-12-18 2009-11-25 Allergan, Inc. Methods and compositions for treating gastrointestinal disorders
WO2008092862A1 (en) * 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Bicyclic derivatives as ep4 agonists
WO2008092861A1 (en) * 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Bicyclic derivatives as ep4 agonists
WO2008092860A1 (en) * 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Bicyclic derivatives as ep4 agonists
GB0810615D0 (en) * 2008-06-10 2008-07-16 Glaxo Group Ltd Novel pharmaceutical
US20110111031A1 (en) * 2009-04-20 2011-05-12 Guang-Liang Jiang Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof
KR20130130694A (ko) * 2010-07-30 2013-12-02 알러간, 인코포레이티드 피부 재생을 위한 화합물과 방법
US8697056B2 (en) * 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods

Similar Documents

Publication Publication Date Title
JP2013544842A5 (https=)
JP2013536183A5 (https=)
RU2013108394A (ru) Соединения и способы восстановления кожи
RU2013129262A (ru) Соединения и способы для восстановления кожи
RU2014113663A (ru) Композиции кожного наполнителя для лечения мелких морщин
JP2013517263A5 (https=)
JP2017214429A5 (https=)
KR102292206B1 (ko) 티로신 유도체 및 이를 포함하는 조성물
KR20100098633A (ko) 자색반병의 치료를 위한 조성물 및 방법
JP2016517431A5 (https=)
JP2018520198A5 (https=)
JP2017533972A5 (https=)
RU2015116264A (ru) Композиции и способы лечения сердечной недостаточности у пациентов с диабетом
CN101972225A (zh) 一种含吡非尼酮的凝胶组合物
JP2016514150A5 (https=)
JP2003528919A5 (https=)
DK2004235T3 (da) Sammensætning til kosmetisk eller farmaceutisk-dermatologisk anvendelse
JP2015537028A5 (https=)
JPWO2007015453A1 (ja) ピリドンカルボン酸誘導体を含有するローション剤
JP2015537028A (ja) 皮膚修復のための組成物および方法
RU2014152196A (ru) Способ улучшения функции печени
MX2018013477A (es) Acidos carboxilicos para tratar/prevenir una enfermedad de la piel.
JP5734953B2 (ja) やけどによる損傷の治療または予防用薬学的組成物
CN106267172A (zh) 一种用于预防瘢痕的组合物及其制备方法和应用
JP2017528517A (ja) 多汗症を治療するための方法